Provectus’s Substack

Provectus’s Substack

About the Substack

A clinical-stage biotechnology company developing immunotherapy medicines for different diseases based on a class of synthetic small molecule halogenated xanthenes, with lead molecule rose bengal sodium.

About Provectus Biopharmaceuticals

We are a clinical-stage biotech developing immunotherapy medicines for different diseases based on a class of small molecules called halogenated xanthenes.